Treatment standards for infectious diseases are changing rapidly – the Elite Research Network can help your study keep up.

Collectively, we have conducted hundreds of infectious disease and vaccine studies from Phase I through Phase IV. Each of our sites utilizes a central IRB to accelerate study start up. Through a combination of our patient databases and selective advertising, our sites typically meet or exceed enrollment goals in the infectious disease studies we conduct, while providing high quality data to our clients.

Due to our therapeutic expertise in infectious disease, we work with our clients in the feasibility and planning stages of their studies. We offer focus groups consisting of investigators, study coordinators, and when appropriate, study participants, in order to establish enrollment expectations and address potential challenges in an effort to minimize cost to the client.